Search

Jerry L Shevitz

from Rockville, MD
Age ~73

Jerry Shevitz Phones & Addresses

  • Rockville, MD
  • 9 Alcott Dr, Livingston, NJ 07039 (973) 992-6956
  • 9 Alcott Dr, Livingston, NJ 07039 (973) 992-6956
  • Margate City, NJ
  • Rego Park, NY
  • Washington, DC
  • East Hanover, NJ
  • 9 Alcott Dr, Livingston, NJ 07039 (609) 713-2594

Work

Position: Clerical/White Collar

Education

Degree: High school graduate or higher

Resumes

Resumes

Jerry Shevitz Photo 1

Jerry Shevitz

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jerry Shevitz
President
Incell
Mfg Electronic Coils/Transformers
9 Alcott Dr, Livingston, NJ 07039
(973) 740-8588

Publications

Us Patents

Fluid Filtration System

View page
US Patent:
6544424, Apr 8, 2003
Filed:
Mar 17, 2000
Appl. No.:
09/527426
Inventors:
Jerry Shevitz - Livingston NJ
Assignee:
Refined Technology Company - East Hanover NJ
International Classification:
B01D 6100
US Classification:
210650, 210636, 21032669, 2102572, 2101952, 2103218
Abstract:
A filtration systems for fluids, particularly biological fluids. The filtration system includes a filter containing compartment connected at one end to a storage vessel and at the other end to a diaphragm pump. The filter comprises a hollow fiber module or a screen filter. The vessel serves as a storage container for a process stream to be filtered. The diaphragm pump provides the means for generating rapid, alternating, low shear tangential flow between the vessel and pump and through the hollow fibers or screen filter. The system allows easy removal of wastes from the fluid and the addition of fresh fluid to replenish the filtered fluid.

Device, System And Process For Modification Or Concentration Of Cell-Depleted Fluid

View page
US Patent:
2013005, Mar 7, 2013
Filed:
Feb 29, 2012
Appl. No.:
13/408243
Inventors:
Jerry Shevitz - Livingston NJ,
International Classification:
B01D 63/02
C12M 1/12
B01D 61/14
US Classification:
4352974, 2102572, 210136, 210650
Abstract:
A product concentration device that utilizes a reservoir connected to a hollow-fiber filter element where the reservoir can serve as a container for filtrate emanating from another filtering device, such that product in the reservoir can be stored, concentrated and/or further processed as desired. Enclosed reactor systems, each of at least three chambers, fluid flow between the chambers controlled by selectively permeable barriers, flow controlled by an alternating flow diaphragm pump.

Fluid Filtration Systems

View page
US Patent:
2013027, Oct 17, 2013
Filed:
Aug 24, 2011
Appl. No.:
13/818679
Inventors:
Jerry Shevitz - Livingston NJ,
International Classification:
B01D 61/58
US Classification:
210151, 210295, 210205
Abstract:
Enclosed reactor systems, each of at least three chambers, fluid flow between the chambers controlled by selectively permeable barriers, flow controlled by an alternating flow diaphragm pump. Also dual diaphragm pump, a diaphragm pump-driven sampling manifold, and a modifier module, all usable with the enclosed reactor systems as well as other systems.

Electrophoretic System And Method For Multidimensional Analysis

View page
US Patent:
4385974, May 31, 1983
Filed:
Jun 24, 1982
Appl. No.:
6/391535
Inventors:
Jerry Shevitz - Livingston NJ
International Classification:
B01D 5702
G01N 2726
G01N 2730
US Classification:
204180G
Abstract:
A system for electrophoretic analysis includes four tanks, each of which carries an electrolytic solution which accesses a different edge surface of a pair of parallel gel plates. The gel plates include an electrophoretic separation path formed of a selected medium, e. g. an isoelectric focusing gel, extending in a space between the plates and across opposite edges of the plates. A pair of nonpolar barrier webs extend between the plates parallel to and on each side of the path. A different medium, e. g. a running gel, occupies the areas between the gel plates from the opposite sides of the barriers to the remaining edges of the plates. A pair of gaskets are positioned along plate edges which are perpendicular to the path. The gaskets include access apertures for the path and the barriers. A specimen is positioned within a channel leading from an electrolytic solution tank to the path aperture of a gasket and between a dam and the aperture.

Preparation And Use Of Immunoconjugates

View page
US Patent:
5443953, Aug 22, 1995
Filed:
Dec 8, 1993
Appl. No.:
8/162912
Inventors:
Hans J. Hansen - Mystic Island NJ
Jerry Shevitz - Livingston NJ
Assignee:
Immunomedics, Inc. - Morris Plains NJ
International Classification:
A61K 39395
C07K 1600
US Classification:
424 149
Abstract:
The present invention relates to immunoconjugates comprising an antibody fragment which is covalently bound to a diagnostic or therapeutic principle through a carbohydrate moiety in the light chain variable region of the antibody fragment. The invention also relates to immunoconjugates comprising an antibody moiety that is an intact antibody containing a glycosylation site in the light chain variable domain which has been introduced into the antibody by mutating the nucleotide sequence encoding the light chain. The resultant immunoconjugates retain the immunoreactivity of the antibody fragment or intact antibody, and target the diagnostic or therapeutic principle to a target tissue where the diagnostic or therapeutic effect is realized. Thus, the invention contemplates the use of such immunoconjugates for diagnosis and immunotherapy. The invention further relates to methods for preparing such immunoconjugates.

Preparation And Use Of Immunoconjugates

View page
US Patent:
5635603, Jun 3, 1997
Filed:
Dec 5, 1994
Appl. No.:
8/352715
Inventors:
Hans J. Hansen - Mystic Island NJ
Jerry Shevitz - Livingston NJ
Gary L. Griffiths - Morristown NJ
Assignee:
Immunomedics, Inc. - Morris Plains NJ
International Classification:
A61K 39395
C07K 1600
US Classification:
5303915
Abstract:
The present invention relates to immunoconjugates comprising an antibody fragment which is covalently bound to a diagnostic or therapeutic principle through a carbohydrate moiety in the light chain variable region of the antibody fragment. The invention also relates to immunoconjugates comprising an antibody moiety that is an intact antibody containing a glycosylation site in the light chain variable domain which has been introduced into the antibody by mutating the nucleotide sequence encoding the light chain. The resultant immunoconjugates retain the immunoreactivity of the antibody fragment or intact antibody, and target the diagnostic or therapeutic principle to a target tissue where the diagnostic or therapeutic effect is realized. Thus, the invention contemplates the use of such immunoconjugates for diagnosis and immunotherapy. The invention further relates to methods for preparing such immunoconjugates.
Jerry L Shevitz from Rockville, MD, age ~73 Get Report